As of 05 Nov 2026 14:06 UTC. Status is always as stated in the latest recorded notice; the sources do not publish resolution, so nothing on this page says a medicine is back — see methodology.
Presentations, as stated in the latest recorded notice
Each line is re-expressed from the latest notice (17 Nov 2025): the product named, the status the source stated, and the expected-back phrase kept as written. Not the source's sentence, and not an observation of stock.
| Presentation | Status, as stated | Expected back, as stated | Stated in |
|---|---|---|---|
| Ibandronic acid 150mg tablets, the only licensed once monthly bisphosphonateaffected product · inferred from phrasing | Limited supply, as stated | March 2026precision: a month · window end 31 Mar 2026, derived from “March 2026” | notice of 17 Nov 2025 |
| Alendronic acid 70mg tablets and risedronate sodium 35mg tablets (once weekly bisphosphonate presentations)named by the source as remaining available · inferred from phrasing · its own page → | Stated as available | — not stated for this line | notice of 17 Nov 2025 |
Protocol in force
No Serious Shortage Protocol matched to this name is in force on the NHSBSA register. Matching is by name until identifier coding lands.
Named in the source as remaining available
- Alendronic acid 70mg tablets and risedronate sodium 35mg tablets (once weekly bisphosphonate presentations) — named by the source as remaining available (inferred from phrasing)
Only names the source itself listed, as it listed them (source post ↗). No substitution, dosing or counselling advice is given here or implied.
Identifiers — Ibandronic Acid
BNF chemical and SNOMED identifiers from NHSBSA Prescription Cost Analysis (Open Government Licence), matched by name (presentation name), confidence 0.90 — grouping under review where marked Release Jul 2026.
BNF SNOMED mapping, NHSBSA Copyright 2026; Prescription Cost Analysis (PCA) Monthly Administrative Data, NHSBSA Copyright 2026. This information is licenced under the terms of the Open Government Licence.
History
One supply notification on record, 17 Nov 2025. We record when a shortage is declared, not when stock returns — the source doesn't publish that. An update sharing a reference counts as one episode.
| Issued | Notice | Kind | Tier | Reference |
|---|---|---|---|---|
| 17 Nov 2025 | Medicine Supply Notification: Ibandronic acid 150mg tablets | Supply notification | Tier 2 | — |
Also recorded under
No other name appears in this medicine's notice titles. Grouping is by the head name in each title; brand and generic names may still sit on separate pages until identifier coding refines it — see the A–Z.
Scotland — separate record
NHS Scotland issues its own Medicine Supply Alert Notices. These match this medicine's name; they are shown beside, never added to, the England record.
- MSAN(2025)50 Ibandronic acid 150mg tablets · issued 19 Nov 2025 · valid until March 2026, as stated · matched by name PDF ↗